ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock Price, Quote, News and Overview
NASDAQ:ASBP - Nasdaq - US7389201077 - Common Stock - Currency: USD
ASBP Quote, Performance and Key Statistics
0.4871
-0.02 (-4.04%)
The current stock price of ASBP is 0.4871 USD. In the past month the price decreased by -26.2%.
ASBP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 68.04 | 838.54B | ||
| JNJ | JOHNSON & JOHNSON | 15.38 | 372.51B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 17.94 | 275.58B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.12 | 221.49B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.76 | 215.69B | ||
| MRK | MERCK & CO. INC. | 10.62 | 208.21B | ||
| PFE | PFIZER INC | 7.37 | 129.99B | ||
| SNY | SANOFI-ADR | 13.38 | 128.08B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.53 | 97.47B | ||
| GSK | GSK PLC-SPON ADR | 8.6 | 75.84B | ||
| ZTS | ZOETIS INC | 25.92 | 68.46B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.98 | 47.30B |
Related stock screener links
About ASBP
Company Profile
Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engaged in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
Company Info
ASPIRE BIOPHARMA HOLDINGS IN
194 Candelaro Drive, #233
Humacao NEW YORK PR
Employees: 0
Company Website: https://www.powerupacq.com/
Investor Relations: https://www.powerupacq.com/investor-relations
Phone: 15617048527
ASPIRE BIOPHARMA HOLDINGS IN / ASBP FAQ
What is the stock price of ASPIRE BIOPHARMA HOLDINGS IN today?
The current stock price of ASBP is 0.4871 USD. The price decreased by -4.04% in the last trading session.
What is the ticker symbol for ASPIRE BIOPHARMA HOLDINGS IN stock?
The exchange symbol of ASPIRE BIOPHARMA HOLDINGS IN is ASBP and it is listed on the Nasdaq exchange.
On which exchange is ASBP stock listed?
ASBP stock is listed on the Nasdaq exchange.
What is ASPIRE BIOPHARMA HOLDINGS IN worth?
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) has a market capitalization of 23.82M USD. This makes ASBP a Nano Cap stock.
How many employees does ASPIRE BIOPHARMA HOLDINGS IN have?
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) currently has 0 employees.
What are the support and resistance levels for ASPIRE BIOPHARMA HOLDINGS IN (ASBP) stock?
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) has a resistance level at 0.59. Check the full technical report for a detailed analysis of ASBP support and resistance levels.
Should I buy ASPIRE BIOPHARMA HOLDINGS IN (ASBP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ASBP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ASBP, evaluating the profitability, health, valuation and growth aspects
- ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Sales and EPS estimates to see what analysts future expectations are.
- ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Insider and Institutional Ownership to learn about the owners and their transactions.
- ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock Chart to make your own analysis
- ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Latest news and press-releases to stay up to date.
Does ASPIRE BIOPHARMA HOLDINGS IN (ASBP) stock pay dividends?
ASBP does not pay a dividend.
What is the Price/Earnings (PE) ratio of ASPIRE BIOPHARMA HOLDINGS IN (ASBP)?
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.43).
What is the Short Interest ratio of ASPIRE BIOPHARMA HOLDINGS IN (ASBP) stock?
The outstanding short interest for ASPIRE BIOPHARMA HOLDINGS IN (ASBP) is 1.33% of its float. Check the ownership tab for more information on the ASBP short interest.
ASBP Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ASBP.
ASBP Financial Highlights
Over the last trailing twelve months ASBP reported a non-GAAP Earnings per Share(EPS) of -0.43. The EPS decreased by -296.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.91% | ||
| ROE | -524.52% | ||
| Debt/Equity | 8.54 |